Latest Drug safety Stories

Clear Majority Opposes Prescription-Only PSE Requirements WASHINGTON, March 21, 2013 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of South Carolina voters conducted by Basswood Research and supported by CHPA. The poll, which surveyed 600 South Carolina voters March 13-14 , found that a 69-percent-majority of South Carolinians oppose a proposed law that would require all consumers to obtain a...

Axia Medical Solutions, maker of the skin care line Dermesse, will be celebrating its 10th anniversary this year. Carlsbad, CA (PRWEB) March 13, 2013 Axia Medical Solutions will be celebrating its 10th anniversary this year. The company began in 2003 as a specialty pharmaceutical company providing prescription strength, over-the-counter, and cosmetic skin care products to the medical professional community. The now popular product line is Dermesse. Several of the founding principles –...

Analysis Finds Prescription-Only Policies Not Worth Costs WASHINGTON, March 8, 2013 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) released a statement today on a recent study conducted by American Enterprise Institute fellow Alex Brill and supported by a grant from CHPA. Brill previously served as the chief economist for the U.S. House Committee on Ways and Means from 2002-2007. His economic policy consulting firm, Matrix Global Advisors, published...

An Essential reference for every family EASTON, Md, March 6, 2013 /PRNewswire-iReach/ -- AVAILABLE WITHOUT A PRESCRIPTION, AN ESSENTIAL REFERENCE FOR EVERY FAMILY FOR MORE INFORMATION Contact: James J Rybacki, Pharm.D. (410) 820-5865 March Sixth, 2013 Easton, Maryland www.EssentialGuideToPrescriptionDrugs.com MORE THAN 2 MILLION SOLD in previous editions! THE ESSENTIAL GUIDE TO PRESCRIPTION DRUGS 12 TOP MEDS OF 2012 Crucial info, key interactions, do's &...

Clear Majority Opposes Prescription-Only PSE Requirements WASHINGTON, March 4, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement today on a recent poll of Indiana voters conducted by The Polling Company and supported by CHPA. The poll, which surveyed 607 Hoosiers on February 4-6(th), found that a 65 percent majority of Hoosiers opposed changing state law to require a doctor's prescription for cold and allergy medicines...

FREDERICK, Md., Feb. 19, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices is pleased to announce that its ActiPatch® Musculoskeletal Pain Relief Therapy product has received a nomination for the "Most Innovative New OTC Product Award" by the OTC Bulletin, the leading international trade publication for OTC developments worldwide. The OTC Bulletin is firmly established as the most...

JERUSALEM, February 14, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in communication with the U.S. Food and Drug Administration (FDA) regarding its Investigational New Drug (IND) application for oral insulin. The FDA has asked Oramed to perform a sub study in a controlled in-patient setting for up to a one-week period. In order to accommodate the FDA's...

WASHINGTON, Feb. 13, 2013 /PRNewswire/ -- Tennessee voters, by a 20-point margin (56 to 36 percent), oppose making common cold and allergy medications containing pseudoephedrine (PSE) available by prescription (Rx) only, and nearly two-thirds of respondents (61 percent) who use nonprescription cold and allergy medicines to treat symptoms oppose the proposal. The new poll, which was conducted by North Star Opinion Research and released today by the Consumer Healthcare Products...

SAN DIEGO, Jan. 30, 2013 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that it has initiated patient recruitment in its pivotal phase 3 clinical study of ANX-188 (purified poloxamer 188) in sickle cell disease. Santosh Vetticaden, Chief Medical Officer, said: "The substantial effort that went into the design of this study is reflected by the enthusiasm that we have heard from thought leaders and clinical sites who wish to participate. In...

First in Special Webinar Series to Address Adverse Drug Reactions UTICA, N.Y., Jan. 22, 2013 /PRNewswire-USNewswire/ -- The Pines Education Institute of Southwest Florida and Utica College have teamed together to present "eMAS: A New Approach to Recognizing Adverse Drug Reactions (ADRs) in Older Adults." The first in a series of webinars for nurses, the presentation will be held Jan. 30 from 10 a.m. to 12 noon, and will focus on avoiding hospitalizations and re-hospitalizations among...